Health Trials

ALL, Adult

2

Review clinical trials related to ALL, Adult. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation

This is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluating the feasibility, safety and preliminary efficacy of an escalating dose regimen of up to 2 doses of TSC-100 and TSC-101 in patients with AML, MDS, or ALL following HCT from a haploidentical donor, MMUD, or MUD

Participants needed: 75
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: TScan Therapeutics, Inc.Updated: Apr 8, 2026Locations: 15
Eligibility criteria

Male or female aged ≥ 18 years at the time of signing the informed consent. [+24]

Medical or psychological conditions that would make the participant an unsuitabl... [+16]

Read more
Status: Recruiting

RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.

In this study, newly diagnosed non-elderly patients with Philadelphia chromosomal negative (PH-) B-ALL were enrolled and 1:1 randomised into Reduced-intensity chemotherapy followed by Blinatumomab cohort or hyperCVAD cohort as induction therapy. The clinical remission rate, MRD negative rate and treaty-related adverse reactions were evaluated.

Participants needed: 124
Trial details
Phase: Phase 2Age: 15-65Biological sex: AllType: InterventionalSponsor: Chen SuningUpdated: Apr 4, 2024Locations: 1
Eligibility criteria

Age 15-65 [+6]

Ph+ (BCR-ABL1 positive) ALL [+9]

Read more